In this issue:
ACVBP ±rituximab for localized low-risk DLBCL
Abbreviated Stanford V and involved-field RT in early-stage HL
R-CVP vs. R-CHOP vs. R-FM for initial advanced-stage FL therapy
Ixabepilone in relapsed aggressive NHL
Everolimus +rituximab i
Please login below to download this issue (PDF)